Index RUT
P/E 21.93
EPS (ttm) 5.89
Insider Own 1.29%
Shs Outstand 24.87M
Perf Week 0.09%
Market Cap 3.22B
Forward P/E 16.97
EPS next Y 7.61
Insider Trans -12.55%
Shs Float 24.61M
Perf Month 5.55%
Income 147.30M
PEG 2.92
EPS next Q 1.37
Inst Own 97.21%
Short Float 0.77%
Perf Quarter 4.63%
Sales 1.94B
P/S 1.66
EPS this Y 9.41%
Inst Trans -0.24%
Short Ratio 2.12
Perf Half Y 18.67%
Book/sh 47.47
P/B 2.72
EPS next Y 14.16%
ROA 8.78%
Short Interest 0.19M
Perf Year 30.69%
Cash/sh 10.83
P/C 11.91
EPS next 5Y 7.50%
ROE 13.03%
52W Range 91.74 - 133.71
Perf YTD 4.73%
Dividend Est. 1.44 (1.12%)
P/FCF 15.35
EPS past 5Y 9.98%
ROI 12.14%
52W High -3.47%
Beta 1.12
Dividend TTM 1.48 (1.15%)
Quick Ratio 1.67
Sales past 5Y 7.45%
Gross Margin 30.89%
52W Low 40.70%
ATR (14) 2.51
Dividend Ex-Date May 17, 2024
Current Ratio 2.50
EPS Y/Y TTM 13.19%
Oper. Margin 8.94%
RSI (14) 59.55
Volatility 1.66% 1.77%
Employees 2400
Debt/Eq 0.04
Sales Y/Y TTM -3.07%
Profit Margin 7.60%
Recom 2.00
Target Price 135.00
Option/Short Yes / Yes
LT Debt/Eq 0.03
EPS Q/Q 24.18%
Payout 25.36%
Rel Volume 0.00
Prev Close 129.07
Sales Surprise -0.78%
EPS Surprise 6.71%
Sales Q/Q -1.84%
Earnings May 09 AMC
Avg Volume 90.02K
Price 129.07
SMA20 3.09%
SMA50 3.47%
SMA200 13.28%
Trades
Volume 0
Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-30-22 Initiated
Seaport Research Partners
Neutral
Sep-04-19 Initiated
CL King
Buy
$95
Apr-12-19 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Apr-24-18 Upgrade
Johnson Rice
Accumulate → Buy
Nov-14-17 Upgrade
Johnson Rice
Hold → Accumulate
Nov-09-17 Downgrade
Monness Crespi & Hardt
Buy → Neutral
Aug-22-17 Upgrade
Monness Crespi & Hardt
Neutral → Buy
$65
Dec-19-16 Downgrade
Monness Crespi & Hardt
Buy → Neutral
Nov-04-16 Reiterated
Monness Crespi & Hardt
Buy
$60 → $62
Aug-04-16 Upgrade
Monness Crespi & Hardt
Neutral → Buy
$60
Apr-05-16 Upgrade
KeyBanc Capital Mkts
Sector Weight → Overweight
Oct-12-15 Downgrade
Monness Crespi & Hardt
Buy → Neutral
Feb-14-14 Reiterated
Monness Crespi & Hardt
Buy
$46 → $53
Feb-14-13 Reiterated
Monness Crespi & Hardt
Buy
$40 → $46
Nov-16-12 Initiated
KeyBanc Capital Mkts
Buy
$40
Nov-02-09 Downgrade
JP Morgan
Overweight → Neutral
Nov-16-07 Upgrade
JP Morgan
Neutral → Overweight
Jun-20-07 Downgrade
Matrix Research
Buy → Hold
Apr-20-07 Downgrade
Matrix Research
Buy → Hold
Show Previous Ratings
May-14-24 06:49AM
May-13-24 07:01PM
09:15AM
May-11-24 09:30AM
May-10-24 12:55PM
06:05PM
Loading…
May-09-24 06:05PM
05:05PM
05:02PM
(Associated Press Finance)
04:45PM
May-02-24 10:00AM
Apr-23-24 12:10PM
Apr-05-24 04:45PM
Apr-03-24 11:24AM
Apr-01-24 09:40AM
Mar-27-24 09:15AM
10:46AM
Loading…
Mar-20-24 10:46AM
Mar-14-24 09:03AM
Mar-11-24 09:15AM
Mar-08-24 09:38AM
Feb-29-24 05:07AM
Feb-27-24 02:02AM
Feb-19-24 09:15AM
Feb-15-24 10:50AM
Feb-14-24 07:58AM
06:41AM
Feb-13-24 06:05PM
05:03PM
(Associated Press Finance)
04:45PM
Jan-11-24 04:45PM
Jan-10-24 08:09AM
12:47PM
Loading…
Dec-12-23 12:47PM
Dec-11-23 04:45PM
Nov-17-23 05:09AM
Nov-13-23 08:37AM
Nov-09-23 02:21PM
01:25AM
(Thomson Reuters StreetEvents)
Nov-07-23 07:03PM
(Associated Press Finance)
04:45PM
Oct-31-23 10:01AM
Oct-26-23 12:10PM
Oct-06-23 04:30PM
Sep-27-23 10:00AM
Aug-10-23 08:25AM
Aug-09-23 11:56PM
(Thomson Reuters StreetEvents)
Aug-08-23 07:15PM
06:13PM
(Associated Press Finance)
04:45PM
Aug-02-23 05:45PM
Jul-19-23 07:34AM
Jul-13-23 02:56PM
Jul-06-23 04:45PM
Jul-02-23 10:47AM
Jun-29-23 09:13AM
08:42AM
Jun-21-23 08:00PM
Jun-20-23 06:19AM
Jun-18-23 09:48AM
Jun-01-23 08:10AM
May-29-23 07:09AM
May-14-23 08:15AM
May-07-23 08:04AM
May-03-23 07:05PM
06:06PM
04:30PM
Apr-26-23 08:00PM
10:01AM
Apr-15-23 01:30PM
Apr-10-23 11:21AM
Apr-07-23 04:45PM
Mar-11-23 08:28AM
Mar-10-23 07:04AM
Feb-25-23 07:48AM
Feb-21-23 06:35PM
04:45PM
Feb-15-23 04:45PM
12:00PM
Feb-09-23 06:01AM
Jan-22-23 09:47AM
Jan-10-23 04:45PM
Jan-08-23 09:25AM
Dec-19-22 11:39AM
10:14AM
Dec-16-22 09:50AM
05:01AM
Dec-15-22 08:01AM
Dec-13-22 10:19AM
Dec-02-22 10:28AM
Dec-01-22 07:18AM
Nov-22-22 09:40AM
Nov-12-22 07:38AM
Nov-10-22 05:55AM
Nov-08-22 07:45PM
04:45PM
Nov-01-22 10:03AM
Oct-12-22 09:00AM
Oct-06-22 04:45PM
Sep-27-22 07:35AM
Sep-26-22 07:11AM
Sep-23-22 09:40AM
08:01AM
Innospec, Inc. engages in the development, manufacture, blend, marketing, and supply of fuel additives, oilfield chemicals, personal care, and other specialty chemicals. It operates through the following segments: Fuel Specialties, Performance Chemicals, and Oilfield Services. The Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives to a range of fuels. The Performance Chemicals segment provides technology-based solutions for customers processes or products focused on the personal care, home care, agrochemical, and mining industries. The Oilfield Services segment refers to the development and marketing of chemical solutions for fracturing, drilling, stimulation, completion operations, products for oil and gas production, and transport. The company was founded in 1938 and is headquartered in Englewood, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PARRETTE LESLIE J Director May 16 '24 Buy 131.57 189 24,867 4,591 May 20 06:07 PM Jones David B. SVP, GC & CCO Mar 01 '24 Sale 125.79 2,500 314,483 9,664 Mar 06 07:19 PM Williams Patrick PRESIDENT & CEO Feb 29 '24 Option Exercise 99.85 3,955 394,907 171,171 Mar 01 07:56 PM Cleminson Ian VP & CFO Feb 29 '24 Option Exercise 99.85 931 92,960 23,927 Mar 01 08:01 PM Williams Patrick PRESIDENT & CEO Feb 29 '24 Sale 124.21 3,955 491,251 167,216 Mar 01 07:56 PM Cleminson Ian VP & CFO Feb 29 '24 Sale 124.07 931 115,508 22,996 Mar 01 08:01 PM Williams Patrick PRESIDENT & CEO Feb 27 '24 Sale 124.47 9,667 1,203,258 167,216 Feb 28 09:11 PM Williams Patrick PRESIDENT & CEO Feb 26 '24 Sale 125.01 9,667 1,208,456 164,667 Feb 27 05:33 PM Williams Patrick PRESIDENT & CEO Feb 23 '24 Sale 124.37 9,667 1,202,249 174,334 Feb 26 07:43 PM Williams Patrick PRESIDENT & CEO Feb 22 '24 Option Exercise 99.85 1,318 131,602 156,318 Feb 26 07:43 PM Jones David B. SVP, GC & CCO Feb 22 '24 Option Exercise 99.85 813 81,178 9,523 Feb 23 06:25 PM Cleminson Ian VP & CFO Feb 22 '24 Option Exercise 99.85 311 31,053 21,308 Feb 26 07:21 PM PARRETTE LESLIE J Director Feb 22 '24 Buy 123.96 410 50,824 3,620 Feb 23 06:19 PM Cleminson Ian VP & CFO Feb 22 '24 Sale 123.77 4,190 518,596 20,997 Feb 26 07:21 PM BOON PHILIP JOHN Executive VP Business Ops Feb 22 '24 Sale 122.07 3,715 453,500 18,516 Feb 26 07:31 PM GRIFFIN HARDY LOUIS III SVP, HUMAN RESOURCES Feb 22 '24 Sale 122.07 1,875 228,886 5,000 Feb 26 07:37 PM Blackmore Milton C Director Feb 22 '24 Sale 122.07 601 73,366 8,246 Feb 26 07:26 PM Jones David B. SVP, GC & CCO Feb 16 '24 Option Exercise 95.70 568 54,358 6,911 Feb 20 06:21 PM Jones David B. SVP, GC & CCO Feb 16 '24 Option Exercise 95.70 189 18,087 6,603 Feb 21 09:08 PM PADFIELD Larry Director Nov 13 '23 Option Exercise 46.03 977 44,971 7,577 Nov 15 09:28 PM PADFIELD Larry Director Nov 13 '23 Sale 101.54 977 99,208 6,600 Nov 15 09:28 PM PALLER Robert I Director Nov 10 '23 Option Exercise 46.03 977 44,971 12,128 Nov 13 08:51 PM Poccia Claudia Director Aug 11 '23 Option Exercise 70.74 424 29,994 1,533 Aug 14 09:33 PM Poccia Claudia Director May 22 '23 Option Exercise 0.00 1,848 0 1,448 May 24 07:48 PM Poccia Claudia Director May 22 '23 Sale 99.20 739 73,306 600 May 24 07:48 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite